Immunome Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Immunome Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q2 2024.
  • Immunome Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 60M shares, a 392% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 60M +47.8M +392% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 59.7M +47.5M +390% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 43.3M +31.1M +257% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 12.2M +74.9K +0.62% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 12.2M +73K +0.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 12.2M +66.8K +0.55% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 12.1M +18.5K +0.15% Dec 31, 2022 10-K 2024-03-28
Q3 2022 12.1M +34.3K +0.28% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 12.1M +315K +2.66% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 12.1M +1.47M +13.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 12.1M +1.48M +13.9% Dec 31, 2021 10-K 2023-03-16
Q3 2021 12.1M +11M +975% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 11.8M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 10.7M Mar 31, 2021 10-Q 2021-05-12
Q4 2020 10.6M +9.53M +867% Dec 31, 2020 10-K 2022-03-28
Q3 2020 1.12M Sep 30, 2020 10-Q 2020-11-16
Q4 2019 1.1M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.